StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > IR stagezero

<< Previous

Bullboard Posts

Next >>

Comment by brad129on Mar 21, 2023 2:30pm

57 Views

Post# 35351813

RE:IR stagezero

brad129 wrote: Just a clip of how IR has replied to true shareholders that Question things.

this was cut out from email

If you are so unhappy with StageZero as an investment, sell your position.

Rebecca

Rebecca Greco
Head of Investor Relations

Me personally, I believe the end of the email should read something like this.
We are working very hard to create value for important investors like yourself and I personally would like to thank you for your continued support.

<< Previous

Bullboard Posts

Next >>

Bombardier delivers Global 6500 aircraft to U.S. Army